$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is Apalutamide a domestic drug or an imported drug and an explanation of the quality differences
2026-02-01 22:25:32
Check Details
How long does it usually take to see significant therapeutic effects from elacestrant?
2026-02-01 22:25:32
Check Details
Safety analysis of whether normal people can take F/TAF for prevention or treatment
2026-02-01 22:25:32
Check Details
Highlights of dosage and taking guidelines in the official instructions for Febuxostat (Febuxostat)
2026-02-01 22:25:32
Check Details
Is there a risk of rapid deterioration of the condition once furmonertinib is discontinued?
2026-02-01 22:25:32
Check Details
When will ensifentrine-Ohtuvayre be launched in China and the latest developments that patients are concerned about
2026-02-01 22:25:32
Check Details
Analysis of the effects of long-term use of Roaccutane (isotretinoin) on the liver and precautions
2026-02-01 22:25:32
Check Details
What are the main indications for Doxorubicin? Applicable tumor types and medication guidelines
2026-02-01 22:25:32
Check Details
Is everolimus (Afinitor) a targeted drug or a chemotherapy drug? The difference between the two and medication guidance
2026-02-01 22:25:32
Check Details
Whether Estramustine has been launched in China and the market supply situation
2026-02-01 22:25:32
Check Details
Analysis of whether Seripase (BRINEURA) is an imported drug or a domestic drug and its market supply situation
2026-02-01 22:25:32
Check Details
Can I take half a tablet of Eslicarbazepine at a time? Scientific basis for dose adjustment
2026-02-01 22:25:32
Check Details
1
2
...
2165
2166
2167
2168
2169
2170
2171
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma